Mesalamine DR 1.2 GM tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FV0X1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,415
Award facts
- Contract value 100% obligated
- $5,414.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,414.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for federal military healthcare programs.
Mesalamine is a gastrointestinal anti-inflammatory medication commonly used to treat inflammatory bowel conditions. As a child contract under the SPE2DX IDC, this delivery order represents a routine pharmaceutical procurement supporting Defense Health Agency medical supply operations. AmerisourceBergen's federal contracting history demonstrates consistent capability in fulfilling pharmaceutical requirements for military and veteran healthcare systems, with an extensive portfolio spanning specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The competitively awarded nature of this contract and AmerisourceBergen's established position as a pharmaceutical prime vendor reinforce its significant role in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FV0X1?
SPE2DB25FV0X1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FV0X1 worth?
The government has obligated $5,415 on SPE2DB25FV0X1.
Is contract SPE2DB25FV0X1 an order under another contract?
Yes. SPE2DB25FV0X1 is a delivery order under SPE2DB20D3505, an indefinite delivery contract.
Was contract SPE2DB25FV0X1 competed?
The extent of competition for SPE2DB25FV0X1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award